HC Wainwright reiterated their buy rating on shares of Elicio Therapeutics (NASDAQ:ELTX – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. HC Wainwright also issued estimates for Elicio Therapeutics’ Q3 2026 earnings at ($0.44) EPS, Q4 2026 earnings at ($0.37) EPS, FY2026 earnings at ($1.83) EPS, Q1 2027 earnings at ($0.35) […]

HC Wainwright reissued their neutral rating on shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) in a research report released on Tuesday morning,Benzinga reports. A number of other equities research analysts have also weighed in on SMMT. Guggenheim lowered their price objective on shares of Summit Therapeutics from $40.00 to $38.00 and set a “buy” […]

HC Wainwright reiterated their buy rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $7.00 target price on the stock. HC Wainwright also issued estimates for Pyxis Oncology’s Q3 2026 earnings at ($0.26) EPS, Q4 2026 earnings at ($0.24) EPS, […]

Cantor Fitzgerald reissued their overweight rating on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. Cantor Fitzgerald currently has a $70.00 price target on the stock. Other equities research analysts also recently issued reports about the stock. Zacks Research raised shares of Quince Therapeutics […]